# ILD Reasoning Platform — High-Risk Mimic Lock Checklist v1

Version: v0.8.6  
Status: pre_seal_lock_checklist  
Scope: High-risk mimic source-limited prompt visibility lock readiness  
Public Ready: false  
Diagnostic Authority: none  
Treatment Authority: none  
Clinically Reviewed: false  

---

## 1. Purpose

This checklist verifies that v0.8 — Deferred Source Expansion / High-Risk Mimic Source Intake is ready for structural sealing.

It does not seal v0.8.  
It does not open full diagnostic domain parity.  
It does not diagnose occupational ILD.  
It does not diagnose pneumoconiosis.  
It does not diagnose asbestosis.  
It does not diagnose chronic beryllium disease.  
It does not diagnose tuberculosis.  
It does not diagnose nontuberculous mycobacterial disease.  
It does not diagnose fungal infection.  
It does not diagnose aspiration-related lung disease.  
It does not diagnose drug-induced ILD.  
It does not diagnose radiation pneumonitis.  
It does not diagnose checkpoint inhibitor pneumonitis.  
It does not diagnose pulmonary lymphangitic carcinomatosis.  
It does not diagnose lymphoma.  
It does not diagnose malignancy.  
It does not diagnose sarcoidosis-like reaction.  
It does not recommend treatment.  
It does not decide biopsy, bronchoscopy, BAL, HRCT, PET/CT, microbiology, serology, occupational testing, therapy discontinuation, immunotherapy management, radiotherapy management, or follow-up interval.  
It does not create public readiness.  
It does not make v0.8 clinically reviewed.

Its role is to confirm that the v0.8 high-risk mimic chain is present, source-governed, testable, source-limited, and non-authoritative before structural seal.

The v0.8 rule remains:

> “Source intake precedes source claims. Source claims precede domain parity.”

---

## 2. v0.8 Chain Under Lock Review

The following v0.8 files must be present before sealing.

| Version | File | Role | Lock Readiness |
|---|---|---|---|
| v0.8.0 | `docs/navigation/deferred_source_expansion_high_risk_mimic_source_intake_entry_gate_v1.md` | Source intake entry gate | required |
| v0.8.1 | `docs/navigation/high_risk_mimic_source_role_map_v1.md` | Source role map | required |
| v0.8.2 | `docs/navigation/high_risk_mimic_claim_to_source_mapping_table_v1.md` | Claim-to-source mapping table | required |
| v0.8.3 | `docs/data/schema/high_risk_mimic_family_matrix_v1.md` | High-risk mimic family matrix | required |
| v0.8.4 | `docs/data/schema/high_risk_mimic_prompt_parity_source_limited_visibility_rules_v1.md` | Source-limited prompt parity | required |
| v0.8.5 | `docs/test_cases/high_risk_mimic_test_case_pack_v1.md` | High-risk mimic test case pack | required |
| v0.8.6 | `docs/navigation/high_risk_mimic_lock_checklist_v1.md` | Pre-seal lock checklist | current |

Lock condition:

- All v0.8.0 through v0.8.5 files must exist.
- Each file must preserve source-limited prompt visibility.
- Each file must preserve non-authority.
- Each file must preserve source role visibility.
- Each file must preserve treatment-heavy source warnings where relevant.
- Each file must preserve diagnostic-performance limitations where relevant.
- Each file must preserve case-example-only limitations where relevant.
- Each file must preserve missing evidence visibility.
- Each file must preserve urgent review visibility where relevant.
- Each file must preserve MDD/specialist review visibility where relevant.
- Domain parity must remain not opened.

---

## 3. Prior Layer Inheritance Checklist

v0.8 must inherit the following prior platform layers.

| Prior Layer | Required Inheritance |
|---|---|
| v0.3 Superimposed Events Core | Multiple processes may coexist; single-label closure remains blocked |
| v0.4 Evidence Layer / Source Review Governance | Source-sensitive claims require anchor, review status, and limitation visibility |
| v0.5 Test Case Coverage Expansion | Missing evidence, mimics, MDD, urgent review, and non-authority remain visible |
| v0.6 UIP Parity Seal | UIP-facing reasoning remains non-diagnostic and source-governed |
| v0.6.R1/R2/R3 | Source-review debt and claim mapping discipline remain visible |
| v0.7 Non-UIP Differential Seal | Differential prompts remain visible without diagnoses |
| checkpoint-v0.7 | v0.8 opens source-first, not expansion-first |

Lock condition:

- v0.8 must not weaken v0.7.
- v0.8 must not convert high-risk mimic prompts into diagnoses.
- v0.8 must not use source intake as domain parity.
- v0.8 must not import treatment or management authority.

---

## 4. Source Intake Lock Checklist

The following source intake classes must remain visible and role-bounded.

| Source Class | Required Lock Behavior |
|---|---|
| primary_high_authority | May support future claim mapping; cannot create diagnosis/treatment authority |
| primary_limited_scope | May support restricted prompt visibility; source limitation must remain visible |
| auxiliary_review | May support context/risk/limitation; cannot replace primary source |
| diagnostic_performance_study | May support feature ambiguity; cannot automate interpretation |
| case_example_cautionary | May inspire test cases; cannot create generalized rules |
| internal_governance | May enforce constraints; cannot replace clinical source |

Lock condition:

- Every admitted source must have a role class.
- Role class must control claim strength.
- Source role must not be hidden in future outputs.
- Treatment-heavy, diagnostic-performance, and case-example limitations must remain visible.

---

## 5. Source Role Map Lock Checklist

v0.8.1 is lock-ready only if the source role map includes:

| Requirement | Required State |
|---|---|
| source_id | present |
| domain family | present |
| source type | present |
| role class | present |
| authority level | present |
| treatment-heavy status | present |
| diagnostic claim eligibility | declared |
| mimic visibility eligibility | declared |
| missing evidence eligibility | declared |
| urgent review eligibility | declared |
| MDD/review eligibility | declared |
| domain parity allowed now | no |

Lock condition:

- Source role mapping reduces source uncertainty.
- Source role mapping does not clear claim-mapping debt by itself.
- Source role mapping does not open domain parity.

---

## 6. Claim-to-Source Mapping Lock Checklist

v0.8.2 is lock-ready only if claim mapping remains non-authoritative.

| Claim Family | Required Lock Behavior |
|---|---|
| occupational exposure / pneumoconiosis / asbestosis | prompt visibility only |
| beryllium / CBD sarcoid mimic | prompt visibility only |
| TB / AFB / NAAT / culture limitation | missing evidence and mimic visibility only |
| NTM clinical-radiologic-microbiologic integration | prompt visibility only |
| fungal mimic / histoplasmosis / aspergillosis / coccidioidomycosis | limited or cautionary prompt visibility only |
| aspiration risk / OP overlap | prompt visibility only |
| drug-induced / therapy-related ILD | review-level mimic visibility only |
| radiation pneumonitis / RILI | source-limited prompt visibility only |
| checkpoint inhibitor pneumonitis | review-level prompt visibility only |
| PLC / malignancy mimic | feature visibility only |
| sarcoid-like reaction / lymphoma / recurrence ambiguity | ambiguity prompt only |
| urgent review | safety visibility only |
| MDD/specialist review | review prompt only |

Lock condition:

- Claim mapping does not create diagnostic authority.
- Claim mapping does not create treatment authority.
- Claim mapping does not create test-order authority.
- Claim mapping does not create procedure authority.
- Claim mapping does not create public readiness.
- Claim mapping does not create clinical review.

---

## 7. High-Risk Mimic Family Matrix Lock Checklist

v0.8.3 is lock-ready only if all families remain prompt families.

| Family | Required Lock Behavior |
|---|---|
| Occupational ILD / pneumoconiosis / asbestosis | exposure/dust mimic prompt only |
| Beryllium sensitivity / CBD | sarcoid-mimic / exposure prompt only |
| TB | infection mimic prompt only |
| NTM | infection mimic / integration prompt only |
| Fungal mimic | limited or cautionary prompt only |
| Aspiration-related disease | aspiration/OP/infection overlap prompt only |
| Drug-induced / therapy-related ILD | medication/therapy temporal prompt only |
| Radiation pneumonitis / RILI | radiation timing/field mimic prompt only |
| Checkpoint inhibitor pneumonitis | ICI exposure pneumonitis mimic prompt only |
| ICI-associated sarcoid-like reaction | recurrence ambiguity prompt only |
| Pulmonary lymphangitic carcinomatosis | malignancy mimic / feature prompt only |
| Malignancy / lymphoma / recurrence | ambiguity prompt only |
| Sarcoid-like reaction in neoplastic patients | recurrence vs benign granulomatous ambiguity prompt only |
| Acute dangerous mimic / unstable overlay | urgent review prompt only |

Lock condition:

- Mimic visibility is not diagnosis.
- Mimic visibility is not exclusion of other mimics.
- Multiple mimics may coexist.
- Acute danger remains higher priority than chronic family naming.

---

## 8. Source-Limited Prompt Parity Lock Checklist

v0.8.4 is lock-ready only if source-limited prompt parity preserves the following.

| Requirement | Required State |
|---|---|
| Occupational prompt without diagnosis | true |
| Beryllium prompt without BeS/CBD diagnosis | true |
| TB/NTM/fungal prompt without infection diagnosis/exclusion | true |
| Aspiration prompt without aspiration diagnosis | true |
| Drug-induced ILD prompt without causality assignment | true |
| Radiation pneumonitis prompt without RP/RILI diagnosis | true |
| ICI pneumonitis prompt without CIP diagnosis | true |
| ICI-SLR prompt without SLR diagnosis | true |
| PLC prompt without PLC/malignancy diagnosis | true |
| Sarcoid-like reaction / lymphoma / recurrence ambiguity preserved | true |
| Missing evidence visible | true |
| Source limitation visible | true |
| Treatment-heavy warning visible where relevant | true |
| Diagnostic-performance warning visible where relevant | true |
| Case-example-only warning visible where relevant | true |
| MDD/specialist review visible | true |
| Urgent review visible where relevant | true |
| Full domain parity remains unopened | true |

Lock condition:

- Source-limited prompt parity is not full diagnostic parity.
- High-risk mimic prompts may be visible, but source-limited prompts are not diagnoses.

---

## 9. Test Case Pack Lock Checklist

v0.8.5 is lock-ready only if all major high-risk mimic families are tested.

| Coverage Domain | Required Coverage |
|---|---|
| Occupational exposure gap | present |
| Pneumoconiosis/asbestosis source-limited visibility | present |
| Beryllium / CBD sarcoid mimic | present |
| BeLPT context without interpretation | present |
| TB / NTM / fungal mimic visibility | present |
| Microbiology missing evidence | present |
| Aspiration / OP-like overlap | present |
| Drug-induced / therapy-related ILD | present |
| Radiation pneumonitis / RILI | present |
| Checkpoint inhibitor pneumonitis | present |
| ICI-associated sarcoid-like reaction | present |
| PLC / malignancy mimic | present |
| Sarcoid-like reaction / lymphoma ambiguity | present |
| Endemic fungal mimic | present |
| Acute danger / urgent review | present |
| Source limitation visibility | present |
| Treatment-heavy source warning | present |
| Diagnostic-performance warning | present |
| Case-example-only warning | present |
| MDD/specialist review | present |
| Diagnostic authority none | present across all test cases |
| Treatment authority none | present across all test cases |
| Public readiness false | present across all test cases |
| Clinically reviewed false | present across all test cases |

Lock condition:

- Every test case must include allowed and blocked outputs.
- Every test case must include source status and source role class.
- Every test case must preserve diagnostic_authority: none.
- Every test case must preserve treatment_authority: none.
- Test cases remain governance tests, not clinical protocols.

---

## 10. Authority Lock Checklist

The following constraints must remain true across v0.8.

| Constraint | Required State |
|---|---|
| diagnostic_authority | none |
| treatment_authority | none |
| public_ready | false |
| clinically_reviewed | false |
| full_domain_parity | not_opened |
| automated_diagnosis | not_allowed |
| automated_exclusion | not_allowed |
| automated_treatment_selection | not_allowed |
| automated_drug_discontinuation | not_allowed |
| automated_immunotherapy_hold_or_restart | not_allowed |
| automated_radiotherapy_plan_change | not_allowed |
| automated_biopsy_decision | not_allowed |
| automated_bronchoscopy_decision | not_allowed |
| automated_BAL_decision | not_allowed |
| automated_microbiology_order | not_allowed |
| automated_HRCT_order | not_allowed |
| automated_PET_CT_order | not_allowed |
| automated_follow_up_schedule | not_allowed |
| patient_facing_use | not_allowed |
| replacement_of_MDD | not_allowed |
| replacement_of_clinician | not_allowed |
| replacement_of_radiologist | not_allowed |
| replacement_of_pathologist | not_allowed |
| replacement_of_pulmonologist | not_allowed |
| replacement_of_rheumatologist | not_allowed |
| replacement_of_microbiology | not_allowed |
| replacement_of_occupational_medicine_review | not_allowed |
| replacement_of_oncology_review | not_allowed |
| replacement_of_radiation_oncology_review | not_allowed |
| replacement_of_urgent_review | not_allowed |

Lock condition:

- No v0.8 document may imply final diagnosis.
- No v0.8 document may imply treatment selection.
- No v0.8 document may imply test ordering.
- No v0.8 document may imply procedure decision.
- No v0.8 document may imply public or patient-facing readiness.

---

## 11. Treatment-Heavy Source Lock Checklist

Treatment-heavy sources must remain constrained.

| Treatment-Heavy Source Area | Required Lock |
|---|---|
| aspergillosis | no antifungal recommendation |
| histoplasmosis | no treatment/no-treatment recommendation |
| aspiration | no antibiotics/swallow/airway/feeding management |
| drug-induced ILD | no drug stop/rechallenge/steroid recommendation |
| radiation pneumonitis / RILI | no steroid or radiotherapy management |
| checkpoint inhibitor pneumonitis | no immunotherapy hold/restart or steroid instruction |
| ICI-associated sarcoid-like reaction | no oncology management import |
| PLC/malignancy case source | no oncology management import |

Lock condition:

> Treatment-heavy sources may support mimic visibility, but treatment authority remains none.

---

## 12. Diagnostic-Performance Source Lock Checklist

Diagnostic-performance sources must remain constrained.

| Diagnostic-Performance Area | Required Lock |
|---|---|
| HRCT/PET-CT PLC performance | feature visibility only |
| PET/CT ambiguity in SLR/lymphoma/recurrence | ambiguity prompt only |
| EBUS/EUS/histology confirmation discussion | review prompt only |
| microbiology criteria and tests | missing evidence prompt only |
| BeLPT context | test context only |

Lock condition:

> Diagnostic-performance evidence may show ambiguity and limitations, but it cannot automate interpretation or management.

---

## 13. Case-Example Source Lock Checklist

Case-example sources must remain cautionary only.

| Case Example Area | Required Lock |
|---|---|
| coccidioidomycosis mimicking sarcoidosis | cautionary example only |
| histoplasmosis vs sarcoidosis | cautionary example only |
| PLC mimicking ILD/infection | cautionary example only |

Lock condition:

> A case report can inspire a test case, not a platform rule.

---

## 14. Missing Evidence Lock Checklist

The following missing evidence domains must remain visible where relevant.

| Missing Evidence | Protected Mimic Families |
|---|---|
| occupational exposure history | occupational ILD; beryllium; pneumoconiosis; asbestosis; sarcoid mimic |
| beryllium exposure context | berylliosis; sarcoidosis mimic |
| BeLPT context | beryllium sensitization / CBD prompt |
| microbiology data | TB; NTM; fungal; sarcoidosis mimic; OP-like consolidation |
| AFB smear / culture / NAAT context | TB mimic |
| repeated sputum / bronchial wash / lavage context | NTM mimic |
| fungal culture / antigen / serology / pathology context | fungal mimic |
| endemic travel or residence | histoplasmosis; coccidioidomycosis; fungal mimic |
| immunosuppression context | fungal; TB; NTM; opportunistic infection; therapy toxicity |
| aspiration risk | aspiration-related lung disease; OP-like consolidation; infection |
| medication / therapy history | DI-ILD; OP-like; NSIP-like; acute injury; ICI-SLR |
| radiation history | RP/RILI; recurrence mimic; drug/ICI overlap |
| radiation field / timing / dose context | RP/RILI |
| checkpoint inhibitor exposure | CIP; ICI-SLR; recurrence mimic |
| malignancy history | PLC; lymphoma; recurrence; SLR |
| PET/CT context | PLC; recurrence; lymphoma; SLR |
| tissue/pathology context | malignancy; infection; granulomatous disease; beryllium; PLC |
| prior imaging | therapy toxicity; recurrence; infection; progression |
| response/nonresponse to empiric therapy | infection; malignancy; DI-ILD; RP; CIP; PLC |
| urgent clinical status | acute infection; severe therapy toxicity; malignancy progression; acute respiratory failure |
| MDD/specialist review status | all high-risk mimic families |

Lock condition:

- Missing evidence must not be silently filled.
- Missing evidence must not be converted into exclusion.
- Missing evidence must not be hidden behind chronic ILD naming.

---

## 15. Overlap Lock Checklist

The following overlaps must remain visible.

| Overlap | Required Behavior |
|---|---|
| Occupational ILD vs HP | Preserve exposure and HP prompts |
| Occupational ILD vs UIP/IPF | Preserve occupational and UIP/IPF boundary prompts |
| Berylliosis vs sarcoidosis | Preserve beryllium exposure and sarcoid-like prompts |
| TB vs sarcoidosis | Preserve TB and sarcoid-like prompts |
| NTM vs sarcoidosis | Preserve NTM and sarcoid-like prompts |
| Fungal infection vs sarcoidosis | Preserve fungal and sarcoid-like prompts |
| Aspiration vs OP | Preserve aspiration and OP-like prompts |
| Aspiration vs infection | Preserve aspiration and infection prompts |
| DI-ILD vs NSIP/OP | Preserve medication history and NSIP/OP prompts |
| DI-ILD vs infection | Preserve medication and infection prompts |
| Radiation pneumonitis vs infection | Preserve RP and infection prompts |
| Radiation pneumonitis vs recurrence | Preserve RP and oncology prompts |
| Radiation pneumonitis vs CIP | Preserve radiation and ICI exposure prompts |
| CIP vs infection | Preserve ICI and infection prompts |
| CIP vs progression | Preserve ICI toxicity and oncology progression prompts |
| ICI-SLR vs malignancy recurrence | Preserve SLR and recurrence ambiguity |
| PLC vs ILD | Preserve PLC and ILD family prompts |
| PLC vs infection/edema | Preserve PLC, infection, and edema prompts |
| Sarcoid-like reaction vs lymphoma relapse | Preserve SLR and lymphoma relapse ambiguity |
| Acute mimic vs chronic fibrosis | Preserve acute danger separately from chronic baseline |

Lock condition:

- Overlap must be represented as coexistence.
- Coexistence must not become one winning label.
- Competing mimics and disease families must not disappear.

---

## 16. Urgent Review Lock Checklist

Urgent review visibility must outrank chronic ILD family naming.

| Urgent Trigger | Required Behavior |
|---|---|
| acute hypoxemia | urgent review prompt visible |
| rapid dyspnea progression | urgent review prompt visible |
| fever or systemic illness | infection/systemic mimic visible |
| hemoptysis or anemia | hemorrhage/malignancy/infection prompt visible |
| immunosuppression | opportunistic infection and therapy toxicity prompts visible |
| known malignancy with new septal thickening | PLC/recurrence mimic visible |
| new FDG-avid lymphadenopathy after cancer therapy | recurrence vs sarcoid-like reaction prompt visible |
| post-radiation new GGO/consolidation | RP vs infection vs recurrence vs drug/ICI prompt visible |
| ICI exposure with new pulmonary findings | CIP vs infection vs progression vs SLR prompt visible |
| nonresponse to empiric therapy | mimic re-review prompt visible |
| severe or worsening respiratory status | urgent clinical review visible |

Lock condition:

- Acute danger must not wait for differential label.
- No urgent condition may be declared excluded by the platform.
- Urgent prompt must not become triage or treatment authority.

---

## 17. Specialist / MDD Review Lock Checklist

Specialist and MDD prompts must remain visible where relevant.

| Review Domain | Required Visibility |
|---|---|
| pulmonology | visible where ILD/mimic uncertainty exists |
| thoracic radiology | visible where HRCT pattern, temporal change, or PET/CT ambiguity is central |
| pathology | visible where granuloma, malignancy, infection, PLC, or tissue ambiguity exists |
| microbiology | visible where TB/NTM/fungal/infectious mimic is possible |
| occupational medicine | visible where exposure or beryllium/pneumoconiosis/asbestosis is possible |
| rheumatology | visible where sarcoid/CTD/immune overlap is possible |
| oncology | visible where malignancy recurrence, PLC, lymphoma, ICI-SLR, or therapy toxicity is possible |
| radiation oncology | visible where RP/RILI/radiation field context is relevant |
| MDD | visible where cross-domain uncertainty or discordance exists |
| urgent clinical review | visible where instability or dangerous acute mimic is possible |

Lock condition:

> Specialist review visibility is not specialist replacement.

---

## 18. Language Guardrail Lock Checklist

Allowed posture examples:

- “Occupational exposure prompt is visible.”
- “Beryllium / sarcoid-mimic prompt remains visible.”
- “TB/NTM/fungal mimic remains visible because microbiology context is incomplete.”
- “Aspiration risk prompt remains visible.”
- “Medication / therapy-related ILD mimic remains visible.”
- “Radiation timing and field context are missing.”
- “ICI exposure creates therapy-related mimic visibility but not diagnosis.”
- “PLC mimic prompt is visible.”
- “Sarcoid-like reaction and malignancy recurrence remain ambiguous.”
- “PET/CT ambiguity does not settle recurrence.”
- “Treatment-heavy source warning is visible.”
- “Case-example source is cautionary only.”
- “MDD / specialist review prompt remains visible.”
- “Urgent review prompt remains visible where relevant.”
- “Final diagnosis is not established by this platform.”
- “diagnostic_authority: none”
- “treatment_authority: none”
- “public_ready: false”
- “clinically_reviewed: false”

Blocked posture examples:

- “Occupational ILD diagnosed.”
- “Asbestosis confirmed.”
- “Berylliosis confirmed.”
- “TB excluded.”
- “NTM excluded.”
- “Fungal infection excluded.”
- “Aspiration pneumonia diagnosed.”
- “Drug-induced ILD confirmed.”
- “Radiation pneumonitis diagnosed.”
- “Checkpoint inhibitor pneumonitis confirmed.”
- “Pulmonary lymphangitic carcinomatosis diagnosed.”
- “Cancer recurrence diagnosed.”
- “Lymphoma relapse excluded.”
- “Sarcoid-like reaction confirmed.”
- “Order PET/CT.”
- “Perform biopsy.”
- “Perform bronchoscopy.”
- “Start antifungal treatment.”
- “Start steroids.”
- “Stop immunotherapy.”
- “Change radiation plan.”
- “Follow up every X months.”
- “MDD unnecessary.”
- “Public-ready.”
- “Clinically reviewed.”

Lock condition:

- Blocked language must not appear as platform-approved output.
- Allowed language must preserve uncertainty, source limitation, and review need.

---

## 19. Drift Risks Blocked Before Seal

This checklist blocks the following risks before v0.8 seal.

| Drift Risk | Required Block |
|---|---|
| Source intake becomes domain parity | domain_parity not opened |
| Mimic prompt becomes diagnosis | diagnostic_authority none |
| Missing evidence becomes exclusion | missing evidence visibility |
| Treatment-heavy source imports management | treatment_authority none |
| Diagnostic-performance source automates interpretation | test interpretation blocked |
| Case report becomes generalized rule | cautionary-only status |
| Occupational exposure becomes causation | causation blocked |
| BeLPT context becomes CBD diagnosis | test interpretation blocked |
| TB/NTM/fungal prompt excludes infection | infection exclusion blocked |
| Aspiration prompt becomes aspiration diagnosis | diagnostic authority blocked |
| DI-ILD prompt becomes drug causality | causality blocked |
| RP/CIP prompt becomes steroid or therapy decision | treatment authority blocked |
| PLC prompt becomes malignancy diagnosis | diagnostic authority blocked |
| SLR source excludes malignancy | malignancy exclusion blocked |
| PET/CT ambiguity settles recurrence | PET interpretation blocked |
| Urgent review omitted in acute danger | urgent review lock |
| MDD/specialist review omitted | review prompt lock |
| Public readiness implied | public_ready false |
| Clinical review implied | clinically_reviewed false |

---

## 20. Pre-Seal Readiness Statement

The v0.8 High-Risk Mimic Source-Limited Prompt Visibility chain is ready for structural sealing only if:

- v0.8.0 through v0.8.5 exist,
- source intake gate exists,
- source role map exists,
- claim-to-source mapping exists,
- family matrix exists,
- source-limited prompt parity exists,
- high-risk mimic test case pack exists,
- all major high-risk mimic families are represented,
- domain parity remains not opened,
- diagnosis remains blocked,
- exclusion remains blocked,
- treatment remains blocked,
- test/procedure/order authority remains blocked,
- source limitations remain visible,
- treatment-heavy warnings remain visible,
- diagnostic-performance warnings remain visible,
- case-example-only warnings remain visible,
- missing evidence remains visible,
- overlap remains visible,
- MDD/specialist review remains visible,
- urgent review remains visible where relevant,
- diagnostic_authority remains none,
- treatment_authority remains none,
- public_ready remains false,
- clinically_reviewed remains false.

This checklist confirms readiness for structural sealing.

It is not itself the seal.

---

## 21. Next Step

If this checklist is accepted, the next step is:

- v0.8.7 — High-Risk Mimic Source-Limited Prompt Visibility Structural Seal

The seal should lock v0.8 as structurally complete while preserving:

- source-first discipline,
- role-mapped sources,
- claim-to-source mapping,
- source-limited prompt parity,
- high-risk mimic test coverage,
- domain parity not opened,
- diagnosis blocked,
- exclusion blocked,
- treatment blocked,
- test/procedure/order authority blocked,
- missing evidence visibility,
- overlap visibility,
- urgent review visibility,
- MDD/specialist review visibility,
- public_ready false,
- clinically_reviewed false.

v0.8.7 must not create diagnostic authority or treatment authority.

---

## 22. Governance Statement

The High-Risk Mimic Lock Checklist prepares v0.8 for structural sealing.

It does not diagnose.  
It does not treat.  
It does not decide biopsy.  
It does not decide bronchoscopy.  
It does not decide BAL.  
It does not decide HRCT, PET/CT, microbiology, serology, occupational testing, therapy discontinuation, immunotherapy management, radiotherapy management, or follow-up interval.  
It does not confirm infection.  
It does not exclude infection.  
It does not confirm malignancy.  
It does not exclude malignancy.  
It does not confirm therapy-related toxicity.  
It does not replace MDD.  
It does not claim public readiness.  
It does not claim clinical review.

The platform remains an evidence-governed clinical reasoning platform.

The current principle remains:

> “It teaches clinicians to read change before naming disease.”

The v0.8 rule remains:

> “Source intake precedes source claims. Source claims precede domain parity.”

This checklist verifies that high-risk mimics remain visible without becoming high-risk mimic diagnoses.